{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T11:29:50Z","timestamp":1713526190921},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/md.0000000000009358","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T02:41:16Z","timestamp":1513910476000},"page":"e9358","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of eculizumab in an adult patient with HIV-associated hemolytic uremic syndrome"],"prefix":"10.1097","volume":"96","author":[{"given":"Marine","family":"Freist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Garrouste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Szlavik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Lautrette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Elisabeth","family":"Heng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-110-20210226","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrneph.2015.9","article-title":"HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment","volume":"11","author":"Rosenberg","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"R2-110-20210226","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/344778","article-title":"Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy","volume":"35","author":"Gervasoni","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R3-110-20210226","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-3083.2008.02143.x","article-title":"Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity","volume":"68","author":"Malak","year":"2008","journal-title":"Scand J Immunol"},{"key":"R4-110-20210226","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2141.2011.08636.x","article-title":"Human immunodeficiency virus associated thrombotic thrombocytopenic purpura: favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy","volume":"153","author":"Hart","year":"2011","journal-title":"Br J Haematol"},{"key":"R5-110-20210226","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.semnephrol.2008.08.007","article-title":"Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient","volume":"28","author":"Fine","year":"2008","journal-title":"Semin Nephrol"},{"key":"R6-110-20210226","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS","volume":"129","author":"Jokiranta","year":"2017","journal-title":"Blood"},{"key":"R7-110-20210226","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R8-110-20210226","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/rheumatology\/kev371","article-title":"A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor","volume":"55","author":"Wig","year":"2016","journal-title":"Rheumatology (Oxford"},{"key":"R9-110-20210226","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11739-017-1636-6","article-title":"Complement blockade in ANCA-associated vasculitis: an index case, current concepts and future perspectives","volume":"12","author":"Manenti","year":"2017","journal-title":"Intern Emerg Med"},{"key":"R10-110-20210226","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/ajt.13183","article-title":"Eculizumab salvage therapy for antibody-mediated rejection in a desensitization-resistant intestinal re-transplant patient","volume":"15","author":"Fan","year":"2015","journal-title":"Am J Transplant"},{"key":"R11-110-20210226","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ndt\/gft470","article-title":"Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab","volume":"29","author":"Delmas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R12-110-20210226","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"R13-110-20210226","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","article-title":"Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial","volume":"68","author":"Fakhouri","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R14-110-20210226","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ckj\/sfw035","article-title":"Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab","volume":"9","author":"Jin","year":"2016","journal-title":"Clin Kidney J"},{"key":"R15-110-20210226","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/infdis\/jiv074","article-title":"HIV coinfection enhances complement activation during sepsis","volume":"212","author":"Huson","year":"2015","journal-title":"J Infect Dis"},{"key":"R16-110-20210226","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"R17-110-20210226","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"key":"R18-110-20210226","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","article-title":"Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation","volume":"12","author":"Zuber","year":"2012","journal-title":"Am J Transplant"},{"key":"R19-110-20210226","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"R20-110-20210226","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ki.2015.60","article-title":"Managing atypical hemolytic uremic syndrome: chapter 2","volume":"87","author":"Nester","year":"2015","journal-title":"Kidney Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:48:50Z","timestamp":1620960530000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201712220-00110"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":20,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009358","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}